Recent studies demonstrated that mTOR was highly activated and continuously up-regulated during human breast cancer progression [40, 41], suggesting that mTOR activation serves as a predictive marker in breast cancer entity, as well as a potential molecular target for anticancer therapy [8, 42]. This evidence concerns the gene MTOR and breast carcinoma.